SotalolAlternative Names: Betapace AF
Latest Information Update: 05 Apr 2007
Price : $50 *
At a glance
- Originator Berlex Laboratories LLC
- Developer Bayer HealthCare Pharmaceuticals Inc.
- Class Antihypertensives; Class III antiarrhythmics; Ethanolamines
- Mechanism of Action Beta-adrenergic receptor antagonists; Potassium channel antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Atrial fibrillation; Atrial flutter